Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion type Assertion NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_head.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion description "[Exquisite, not infrequently fatal, sensitivity to neuroleptic drugs and encouraging reports of the effects of cholinesterase inhibitors on cognitive, psychiatric and neurological features, mean that an accurate diagnosis of DLB is more than merely of academic interest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion evidence source_evidence_literature NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion SIO_000772 12567332 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion wasDerivedFrom befree-2016 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion wasGeneratedBy ECO_0000203 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.